Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Bioanalytical Systems, Inc.    BASI

BIOANALYTICAL SYSTEMS, INC.

(BASI)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

BIOANALYTICAL SYSTEMS INC : Regulation FD Disclosure (form 8-K)

09/16/2020 | 02:03pm EST

Item 7.01 Regulation FD Disclosure

Management of Bioanalytical Systems, Inc. (the "Company") will present at the H.C. Wainwright Investment Conference on September 16, 2020. A copy of the presentation slides for the conference is furnished as Exhibit 99.1 to this report. As previously announced, a live webcast of the presentation will be available through a link that will be posted on the Investors section of the Company's website at ir.inotivco.com and will be available for approximately 90 days.

The information furnished under Item 7.01 of this Current Report on Form 8-K and in Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

© Edgar Online, source Glimpses

All news about BIOANALYTICAL SYSTEMS, INC.
10/20BIOANALYTICAL : Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice..
AQ
10/20Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice President, P..
GL
09/18BIOANALYTICAL SYSTEMS INC : Results of Operations and Financial Condition, Finan..
AQ
09/16BIOANALYTICAL SYSTEMS INC : Regulation FD Disclosure (form 8-K)
AQ
09/09BIOANALYTICAL : BASi to Participate in H.C. Wainright Investment Conference
AQ
09/09BASi to Participate in H.C. Wainright Investment Conference
GL
08/14BIOANALYTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
08/14BASi Releases Earnings for Third Quarter of Fiscal 2020
GL
08/11BIOANALYTICAL : I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Tox..
AQ
07/15MERCK : to Invest EUR18 Million in Swiss Laboratory
DJ
More news
Financials (USD)
Sales 2019 43,6 M - -
Net income 2019 -0,79 M - -
Net Debt 2019 16,0 M - -
P/E ratio 2019 -44,9x
Yield 2019 -
Capitalization 77,6 M 77,6 M -
EV / Sales 2018 0,96x
EV / Sales 2019 1,23x
Nbr of Employees 317
Free-Float 65,4%
Chart BIOANALYTICAL SYSTEMS, INC.
Duration : Period :
Bioanalytical Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOANALYTICAL SYSTEMS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers
NameTitle
Robert Leasure President, Chief Executive Officer & Director
Gregory C. Davis Chairman
Beth A. Taylor Chief Financial Officer & Vice President-Finance
Richard Allen Johnson Independent Director
Wendy Perrow Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOANALYTICAL SYSTEMS, INC.42.63%78
MODERNA, INC.705.88%62 229
LONZA GROUP AG52.83%45 010
CELLTRION, INC.109.94%42 993
SEAGEN INC.57.68%32 484
IQVIA HOLDINGS INC.8.49%32 139